Esperion Therapeutics Inc
ESPR1.070USD
-0.030-2.73%
收盘 06/20, 16:00（美东）报价延迟15分钟
210.43M总市值
亏损市盈率 TTM
关于 Esperion Therapeutics Inc 公司
Esperion Therapeutics, Inc. 是一家制药公司。该公司专注于开发和商业化口服、每日一次、非他汀类药物，用于治疗低密度脂蛋白胆固醇 (LDL-C) 升高的患者。该公司的产品包括 NEXLETOL、NEXLIZET、NILEMDO 和 NUSTENDI。该公司的 NEXLETOL 和 NEXLIZET（贝培多酸和依折麦布）片剂是口服、每日一次、非他汀类药物，用于治疗患有杂合子家族性高胆固醇血症 (HeFH) 或动脉粥样硬化性心血管疾病 (ASCVD) 的成人原发性高脂血症。其 NEXLETOL 是一种 ATP 柠檬酸裂解酶 (ACL) 抑制剂，可通过减少胆固醇生物合成和上调 LDL 受体来降低 LDL-C。其 NUSTENDI 含有贝培多酸和依折麦布，通过互补作用机制抑制肝脏胆固醇合成和肠道吸收，从而降低升高的 LDL-C。其在研产品包括下一代 ACLYi。
公司简介
公司代码ESPR
公司名称Esperion Therapeutics Inc
上市日期Jun 24, 2013
成立日期2008
CEOMr. Sheldon L. Koenig
员工数量304
证券类型Ordinary Share
年结日Jun 24
公司地址3891 Ranchero Drive, Suite 150
城市ANN ARBOR
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编48108
电话17348873903
网址https://www.esperion.com/
公司代码ESPR
上市日期Jun 24, 2013
成立日期2008
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sheldon L. Koenig
Mr. Sheldon L. Koenig
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
278.23K
-9.87%
Mr. Benjamin (Ben) Halladay
Mr. Benjamin (Ben) Halladay
Chief Financial Officer
Chief Financial Officer
83.51K
-7.97%
Mr. Stephen C. Rocamboli, J.D.
Mr. Stephen C. Rocamboli, J.D.
Independent Director
Independent Director
69.26K
+91.01%
Ms. Tracy M. Woody
Ms. Tracy M. Woody
Independent Director
Independent Director
33.57K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
5.28K
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Ms. Alina Venezia
Ms. Alina Venezia
IR Contact Officer
IR Contact Officer
--
--
Mr. J. Martin (Marty) Carroll
Mr. J. Martin (Marty) Carroll
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Benjamin O. Looker, Esq.
Mr. Benjamin O. Looker, Esq.
General Counsel
General Counsel
--
--
Mr. Jay P. Shepard
Mr. Jay P. Shepard
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Sheldon L. Koenig
Mr. Sheldon L. Koenig
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
278.23K
-9.87%
Mr. Benjamin (Ben) Halladay
Mr. Benjamin (Ben) Halladay
Chief Financial Officer
Chief Financial Officer
83.51K
-7.97%
Mr. Stephen C. Rocamboli, J.D.
Mr. Stephen C. Rocamboli, J.D.
Independent Director
Independent Director
69.26K
+91.01%
Ms. Tracy M. Woody
Ms. Tracy M. Woody
Independent Director
Independent Director
33.57K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
5.28K
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.73%
The Vanguard Group, Inc.
5.80%
Wasatch Global Investors Inc
5.52%
Bellevue Asset Management AG
4.89%
Two Seas Capital LP
3.50%
Other
73.57%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
6.73%
The Vanguard Group, Inc.
5.80%
Wasatch Global Investors Inc
5.52%
Bellevue Asset Management AG
4.89%
Two Seas Capital LP
3.50%
Other
73.57%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
21.60%
Investment Advisor
19.65%
Hedge Fund
11.20%
Research Firm
6.05%
Bank and Trust
0.67%
Individual Investor
0.55%
Pension Fund
0.14%
Insurance Company
0.02%
Other
40.10%
机构持股
更新时间: 2月24日 周一
更新时间: 2月24日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
392
118.99M
60.06%
-48.18M
2024Q4
416
132.03M
67.01%
-41.92M
2024Q3
411
131.82M
67.24%
-43.99M
2024Q2
396
139.50M
73.71%
-8.75M
2024Q1
381
127.67M
67.51%
+27.09M
2023Q4
370
73.40M
64.38%
-30.67M
2023Q3
392
79.14M
69.19%
-24.19M
2023Q2
397
76.08M
79.96%
-27.32M
2023Q1
402
81.51M
91.10%
-9.43M
2022Q4
408
75.17M
98.39%
-2.65M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
13.09M
6.61%
-88.25K
-0.67%
Dec 31, 2024
The Vanguard Group, Inc.
11.72M
5.92%
-1.33M
-10.18%
Dec 31, 2024
Wasatch Global Investors Inc
24.48M
12.37%
+1.14M
+4.87%
Dec 31, 2024
Bellevue Asset Management AG
9.69M
4.9%
-250.00K
-2.51%
Mar 04, 2025
Two Seas Capital LP
6.23M
3.15%
-353.41K
-5.37%
Dec 31, 2024
Morgan Stanley & Co. LLC
5.06M
2.56%
+2.82M
+126.34%
Dec 31, 2024
Two Sigma Investments, LP
7.16M
3.62%
-68.60K
-0.95%
Dec 31, 2024
State Street Global Advisors (US)
4.50M
2.28%
+649.92K
+16.86%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.34M
2.19%
+8.63K
+0.20%
Dec 31, 2024
Meditor Capital Management Limited
3.79M
1.92%
--
--
Sep 30, 2024
查看更多
持股ETF
更新时间: 6月6日 周五
更新时间: 6月6日 周五
机构名称
占比
Virtus LifeSci Biotech Products ETF
0.58%
SPDR S&P Pharmaceuticals ETF
0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.33%
Principal U.S. Small-Cap ETF
0.06%
iShares Micro-Cap ETF
0.04%
Invesco Nasdaq Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Virtus LifeSci Biotech Products ETF
占比0.58%
SPDR S&P Pharmaceuticals ETF
占比0.4%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比0.33%
Principal U.S. Small-Cap ETF
占比0.06%
iShares Micro-Cap ETF
占比0.04%
Invesco Nasdaq Biotechnology ETF
占比0.02%
ProShares Ultra Nasdaq Biotechnology
占比0.02%
iShares Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
